Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This study has been designed as a multicentre, randomised, double-blind study of AVT02 in healthy adult subjects. The study will assess the PK, safety and tolerability of AVT02 compared to EU-Humira and US licenced Humira (US-Humira), when administered as a single 40 mg SC dose.
Epistemonikos ID: c83e725daaa821a01a94b5ef7022c2bd2e9e6e5a
First added on: May 22, 2024